ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,996.66
1.00%
US Tech 100
20,877.20
1.72%
다우존스 지수
43,487.83
0.78%
Bitcoin
107,908.33
4.65%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. Caribou Biosciences Inc (CRBU) 시세

Caribou Biosciences Inc

Caribou Biosciences Inc (CRBU)

Amd Commo Exagr
1.53
-0.01
(-0.65%)
마감 20 1월 6:00AM
15분 지연
1.559
0.029
(1.90%)
시간외 거래: 8:36AM
15분 지연

개인 투자자를 위한 전문가급 도구.

프리미엄

주요 통계 및 세부정보

가격
1.559
매수가
1.50
매도가
1.98
거래량
1,027,668
1.52 일간 변동폭 1.58
1.50 52주 범위 8.33
market_cap
141.172M
전일 종가
1.54
개장가
1.58
최근 거래 시간
5
@
1.56
마지막 거래 시간
재정 규모
US$ 1,586,157
VWAP
1.5435
평균 볼륨(3m)
1,647,038
발행 주식
90,552,687
배당수익률
-
주가수익률
-1.36
주당순이익(EPS)
-1.13
매출
34.48M
순이익
-102.07M

Caribou Biosciences Inc 정보

Caribou Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. Caribou Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies.

섹터
Biological Pds,ex Diagnstics
산업
Biological Pds,ex Diagnstics
웹사이트
www.cariboubio.com
본부
Dover, Delaware, USA
설립됨
-
Caribou Biosciences Inc is listed in the Biological Pds,ex Diagnstics sector of the 나스닥 with ticker CRBU. The last closing price for Caribou Biosciences was US$1.54. Over the last year, Caribou Biosciences shares have traded in a share price range of US$ 1.50 to US$ 8.33.

Caribou Biosciences currently has 90,552,687 shares in issue. The market capitalisation of Caribou Biosciences is US$139.45 million. Caribou Biosciences has a price to earnings ratio (PE ratio) of -1.36.

CRBU 최신 뉴스

추가 뉴스

CRBU LAWSUIT ALERT: The Gross Law Firm Notifies Caribou Biosciences, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

CRBU LAWSUIT ALERT: The Gross Law Firm Notifies Caribou Biosciences, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline PR Newswire NEW YORK, Jan. 16, 2025 NEW YORK, Jan. 16, 2025...

16 1월 2025
PR Newswire (US)

Form 8-K - Current report

13 1월 2025
Edgar (US Regulatory)

Shareholders of Caribou Biosciences, Inc. Should Contact The Gross Law Firm Before February 24, 2025 to Discuss Your Rights - CRBU

Shareholders of Caribou Biosciences, Inc. Should Contact The Gross Law Firm Before February 24, 2025 to Discuss Your Rights - CRBU PR Newswire NEW YORK, Jan. 13, 2025 NEW YORK, Jan. 13, 2025...

13 1월 2025
PR Newswire (US)

Caribou Biosciences Initiates the CB-010 GALLOP Phase 1 Trial in Lupus and Provides Outlook for Multiple Clinical Datasets in 2025

-- CB-010 GALLOP Phase 1 trial initiated in lupus -- -- CB-012 AMpLify Phase 1 trial in r/r AML completes dose level 3 with no DLTs; enrolling patients at dose level 4 -- -- CB-010 ANTLER 2L...

13 1월 2025
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

11 1월 2025
Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities

11 1월 2025
Edgar (US Regulatory)

Class Action Filed Against Caribou Biosciences, Inc. (CRBU) Seeking Recovery for Investors - Contact The Gross Law Firm

Class Action Filed Against Caribou Biosciences, Inc. (CRBU) Seeking Recovery for Investors - Contact The Gross Law Firm PR Newswire NEW YORK, Jan. 9, 2025 NEW YORK, Jan. 9, 2025 /PRNewswire/...

09 1월 2025
PR Newswire (US)

Caribou Biosciences to Present at 43rd Annual J.P. Morgan Healthcare Conference

BERKELEY, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced that...

08 1월 2025
GlobeNewswire Inc.

The Gross Law Firm Reminds Caribou Biosciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 24, 2025 - CRBU

The Gross Law Firm Reminds Caribou Biosciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 24, 2025 - CRBU PR Newswire NEW YORK, Jan. 6, 2025...

06 1월 2025
PR Newswire (US)

Class Action Filed Against Caribou Biosciences, Inc. (CRBU) Seeking Recovery for Investors - Contact The Gross Law Firm

Class Action Filed Against Caribou Biosciences, Inc. (CRBU) Seeking Recovery for Investors - Contact The Gross Law Firm PR Newswire NEW YORK, Jan. 2, 2025 NEW YORK, Jan. 2, 2025 /PRNewswire/...

03 1월 2025
PR Newswire (US)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.111-6.646706586831.671.711.518725691.57474908CS
4-0.211-11.92090395481.772.041.515875961.67717853CS
12-0.301-16.18279569891.862.99951.516470382.03641562CS
26-1.041-40.03846153852.62.99951.512731722.05395996CS
52-3.551-69.49119373785.118.331.516592003.137518CS
156-9.651-86.092774308711.2113.191.513288675.17350827CS
260-16.091-91.167138810217.6532.6451.512329826.37462939CS

CRBU - Frequently Asked Questions (FAQ)

What is the current Caribou Biosciences share price?
The current share price of Caribou Biosciences is US$ 1.559
How many Caribou Biosciences shares are in issue?
Caribou Biosciences has 90,552,687 shares in issue
What is the market cap of Caribou Biosciences?
The market capitalisation of Caribou Biosciences is USD 139.45M
What is the 1 year trading range for Caribou Biosciences share price?
Caribou Biosciences has traded in the range of US$ 1.50 to US$ 8.33 during the past year
What is the PE ratio of Caribou Biosciences?
The price to earnings ratio of Caribou Biosciences is -1.36
What is the cash to sales ratio of Caribou Biosciences?
The cash to sales ratio of Caribou Biosciences is 4.02
What is the reporting currency for Caribou Biosciences?
Caribou Biosciences reports financial results in USD
What is the latest annual turnover for Caribou Biosciences?
The latest annual turnover of Caribou Biosciences is USD 34.48M
What is the latest annual profit for Caribou Biosciences?
The latest annual profit of Caribou Biosciences is USD -102.07M
What is the registered address of Caribou Biosciences?
The registered address for Caribou Biosciences is 3500 S DUPONT HWY, KENT, DOVER, DELAWARE, 19901
What is the Caribou Biosciences website address?
The website address for Caribou Biosciences is www.cariboubio.com
Which industry sector does Caribou Biosciences operate in?
Caribou Biosciences operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
BTCTBTC Digital Ltd
US$ 8.2697
(73.73%)
61.45M
BDMDBaird Medical Investment Holdings Ltd
US$ 8.80
(62.36%)
18.63M
CRKNCrown Electrokinetics Corporation
US$ 0.1235
(54.96%)
764.86M
NUKKNukkleus Inc
US$ 29.97
(45.98%)
19.09M
GSITGSI Technology
US$ 3.97
(44.36%)
87.7M
DOGZDogness International Corporation
US$ 18.23
(-58.77%)
740.45k
ORKTOrangeKloud Technology Inc
US$ 3.02
(-24.88%)
21.08M
PMAXPowell Max Ltd
US$ 0.6364
(-23.31%)
4.17M
LGCBLinkage Global Inc
US$ 0.2876
(-22.27%)
890.66k
YYAIConnexa Sports Technologies Inc
US$ 0.8299
(-20.20%)
602.48k
CRKNCrown Electrokinetics Corporation
US$ 0.1235
(54.96%)
764.86M
GCTKGlucoTrack Inc
US$ 0.0852
(15.45%)
465.22M
RIMEAlgorhythm Holdings Inc
US$ 0.0406
(-4.02%)
387.23M
TGLTreasure Global Inc
US$ 0.2459
(14.75%)
267.1M
NVDANVIDIA Corporation
US$ 137.71
(3.10%)
201.4M

CRBU Discussion

게시물 보기
Monksdream Monksdream 2 주 전
CRBU. Under $2
👍️0
Monksdream Monksdream 4 주 전
CRBU under $2
👍️0
TrendTrade2016 TrendTrade2016 2 월 전
CRBU READY TO BEAST
👍️0
TrendTrade2016 TrendTrade2016 3 월 전
CRBU...NEW SCAN JUST GAVE ME THIS BIO
👍️0
Monksdream Monksdream 3 월 전
CRBU under $3
👍️0
Monksdream Monksdream 3 월 전
CRBU under $2
👍️0
Monksdream Monksdream 5 월 전
CRBU under $3
👍️0
Monksdream Monksdream 6 월 전
CRBU under $3
👍️0
jondoeuk jondoeuk 6 월 전
Earlier this year development of the lead CAR-NK programme, CB-020, was stopped, and now they are out of CAR-NK altogether. They disclosed it in an SEC filing and outlined a 12% workforce reduction https://www.sec.gov/Archives/edgar/data/1619856/000161985624000054/crbu-20240716.htm

This should extend their cash runway by at least six months, into the second half of 2026.
👍️0
Monksdream Monksdream 6 월 전
CRBU under $3
👍️0
Monksdream Monksdream 7 월 전
CRBU new 52 week low
👍️0
Monksdream Monksdream 7 월 전
CRBU new 52 week low
👍️0
NY1972 NY1972 7 월 전
Without engaging macrophage long term, CART and other ACT will have persistence issue as regulatory lymphocytes and TAM recoup. AFMD has the best approach with ICE engaging a few B CBNK cells for start and engaging endogenous NK and M in the maintenance phase
👍️0
Diego Rivas Diego Rivas 8 월 전
Any good news in here comming?
👍️0
jondoeuk jondoeuk 8 월 전
Among patients with four or more matching HLA alleles, mPFS was 14.4 months, versus 2.8 months in patients with three or fewer matches. But this is based on a retrospective analysis, so they will need to prove the theory prospectively. It was better in LBCL, with mPFS not reached, versus 2.8 months. Also, some improvement in the now-selected dose, 80 million CAR-T cells.
👍️0
jondoeuk jondoeuk 8 월 전
The BCMA-targeted space is already crowded enough and off-target toxicities, including agranulocytosis* could be a problem for its anti-CLL-1 CAR.

* CLL-1 is also highly expressed on almost all granulocytes and monocytes and on parts of myeloid progenitors in the normal bone marrow and peripheral blood.
👍️0
Monksdream Monksdream 8 월 전
CRBU new 52 week low
👍️0
stocksrising stocksrising 8 월 전
Yep, not a positive trend hence sub $3’s…fortunately other trials for varied indications could save company…
👍️0
jondoeuk jondoeuk 8 월 전
It gets worse. The updated (CB-010) data shows that the ORR (including CR rate) has fallen, so has the mDOR, the six-month PFS is poor and the pivotal trial has been delayed until H2 2025 following a new HLA partial matching strategy. The latter completely alters (in a bad way) the commercial strategy for an allo CAR-T product. They now need thirteen different off-the-shelf batches to be able to cater to ~90% of patients based on an ideal HLA match.
👍️ 1
Monksdream Monksdream 8 월 전
CRBU new 52 week low
👍️0
Monksdream Monksdream 8 월 전
CRBU new 52 week low
👍️0
Monksdream Monksdream 9 월 전
CRBU under $5
👍️0
stocksrising stocksrising 10 월 전
It seemed like they were running on all positive cylinders, but must have blown a gasket at current Conference/ Fireside???
👍️0
Monksdream Monksdream 1 년 전
CRBU new 52 week low
👍️0
jondoeuk jondoeuk 2 년 전
Yes, with both drugs still in development. As for CRBU, they gave an update (plus public offering) https://finance.yahoo.com/news/caribou-biosciences-reports-positive-clinical-200100822.html https://investor.cariboubio.com/static-files/d818ed1a-aea2-41c1-84ea-bd05a4276cbb

Personally, there seem to be red flags, such as no expansion/persistence data. I know they give huge amounts of LD chemo, higher (I think) than anyone else, which could be generating responses, explaining why there is no dose response.
👍️0
trueblue trueblue 2 년 전
.
👍️0
trueblue trueblue 2 년 전
$23.00 price target! Now that is a good start!! Glad I loaded up! Jmo
👍️0
NY1972 NY1972 2 년 전
Didn't they buy TRIL? Just gambling with billions from US government.
👍️0
jondoeuk jondoeuk 2 년 전
PFE is very selective in who they fund https://finance.yahoo.com/news/caribou-biosciences-announces-25-million-120000433.html
👍️0
trueblue trueblue 2 년 전
Great day in my accounts again! Really liking my CRBU shares! Jmo holding for the long haul!!
👍️0
Monksdream Monksdream 2 년 전
CRBU now No 9 on the Barchart Top 10
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
👍️0
trueblue trueblue 2 년 전
Added to my existing shares today, I bought shares months ago. I like Crbu a crisper company! Looks like Pfizer does also! Jmo
👍️0
Stockexpertpro Stockexpertpro 2 년 전
CRBU Loss 108 Million Dollars Company only has preclinical and phase 1 in its pipeline company is Years away from having anything if ever did a stock offering at 5.33$ for 25 Million thats only 1 QTR Cash burn for this company Sell the News https://www.cariboubio.com/pipeline/
👍️0
TheFinalCD TheFinalCD 2 년 전
CRBU= JUST WOW

https://finviz.com/quote.ashx?t=CRBU&ty=c&ta=1&p=d
👍️0
Monksdream Monksdream 2 년 전
CRBU No 1 on the early Barchart Top 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
👍️0

최근 히스토리

NASDAQ
CRBU
Caribou Biosciences
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유